Abstract
Five percent of 145 HIV-1 infected men enrolled in an assisted reproductive technology (ART) program harbored detectable HIV-1 RNA in semen, although they had no other sexually transmitted disease and their blood viral load was undetectable for at least 6 months under antiretroviral treatment. This result justifies measuring HIV-1 RNA in semen before the ART process and suggests that a residual risk of transmission has to be mentioned to the patients who would like to have unprotected sexual intercourse.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adult
-
Anti-Retroviral Agents / therapeutic use
-
Antiretroviral Therapy, Highly Active
-
HIV Infections / drug therapy
-
HIV Infections / transmission
-
HIV Infections / virology*
-
HIV-1 / genetics*
-
Humans
-
Infectious Disease Transmission, Vertical
-
Male
-
Middle Aged
-
Plasma / virology
-
RNA, Viral / analysis*
-
RNA, Viral / blood
-
Reproductive Techniques, Assisted
-
Risk
-
Semen / virology*
-
Viral Load / methods
Substances
-
Anti-Retroviral Agents
-
RNA, Viral